Remix Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-04. The offering totals $90.0M, of which $13.7M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Scott Biller | Director | Watertown, MA |
| Kevin Bitterman | Director | Cambridge, MA |
| Jeff Goater | Director | New York, NY |
| Matthew Patterson | Director | South San Francisco, CA |
| Michael Rome | Director | Palm Beach, FL |
| Peter Smith | Director | Branchburg, NJ |
| Robert Gagnon | Executive Officer | Rehovot, L3 |
| Peter Smith | Executive Officer | Branchburg, NJ |
| Heather Wasserman | Executive Officer | Watertown, MA |